Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive...
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
About this item
Full title
Author / Creator
Beckabir, Wolfgang , Zhou, Mi , Lee, Jin Seok , Vensko, Steven P. , Woodcock, Mark G. , Wang, Hsing-Hui , Wobker, Sara E. , Atassi, Gatphan , Wilkinson, Alec D. , Fowler, Kenneth , Flick, Leah M. , Damrauer, Jeffrey S. , Harrison, Michael R. , McKinnon, Karen P. , Rose, Tracy L. , Milowsky, Matthew I. , Serody, Jonathan S. , Kim, William Y. and Vincent, Benjamin G.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Neoadjuvant cisplatin-based chemotherapy is standard of care for muscle-invasive bladder cancer (MIBC). Immune checkpoint inhibition (ICI) alone, and ICI in combination with chemotherapy, have demonstrated promising pathologic response (
Alternative Titles
Full title
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Authors, Artists and Contributors
Author / Creator
Zhou, Mi
Lee, Jin Seok
Vensko, Steven P.
Woodcock, Mark G.
Wang, Hsing-Hui
Wobker, Sara E.
Atassi, Gatphan
Wilkinson, Alec D.
Fowler, Kenneth
Flick, Leah M.
Damrauer, Jeffrey S.
Harrison, Michael R.
McKinnon, Karen P.
Rose, Tracy L.
Milowsky, Matthew I.
Serody, Jonathan S.
Kim, William Y.
Vincent, Benjamin G.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_20a284baf2454780aedd68c631ea83b7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_20a284baf2454780aedd68c631ea83b7
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-024-48480-1
